What is the cost of diagnosis and management of drug resistant tuberculosis in South Africa?
about
The diagnostic accuracy of the GenoType(®) MTBDRsl assay for the detection of resistance to second-line anti-tuberculosis drugsDrug-resistant TB: deadly, costly and in need of a vaccineT-Cell Therapy: Options for Infectious DiseasesBedaquiline for the treatment of multidrug-resistant tuberculosis: great promise or disappointment?Immunogenicity without Efficacy of an Adenoviral Tuberculosis Vaccine in a Stringent Mouse Model for Immunotherapy during TreatmentGenoType® MTBDRsl assay for resistance to second-line anti-tuberculosis drugsAnti-tuberculosis drug resistance among new and previously treated sputum smear-positive tuberculosis patients in Uganda: results of the first national surveyGlobal financing and long-term technical assistance for multidrug-resistant tuberculosis: scaling up access to treatmentDevelopment and evaluation of a pilot nurse case management model to address multidrug-resistant tuberculosis (MDR-TB) and HIV in South AfricaHigh frequency of resistance, lack of clinical benefit, and poor outcomes in capreomycin treated South African patients with extensively drug-resistant tuberculosisCost-Effectiveness of Community-Based TB/HIV Screening and Linkage to Care in Rural South AfricaAdverse or acceptable: negotiating access to a post-apartheid health care contractGlobal control of tuberculosis: from extensively drug-resistant to untreatable tuberculosisInterpersonal psychotherapy versus treatment as usual for PTSD and depression among Sichuan earthquake survivors: a randomized clinical trial.Drug-resistant tuberculosis control in South Africa: scientific advances and health system strengthening are complementaryMycobacterial DNA extraction for whole-genome sequencing from early positive liquid (MGIT) cultures.Implementing a large-scale systematic tuberculosis screening program in correctional facilities in South Africa.Rapid determination of anti-tuberculosis drug resistance from whole-genome sequencesImpact of reduced hospitalisation on the cost of treatment for drug-resistant tuberculosis in South Africa.Rationing tests for drug-resistant tuberculosis - who are we prepared to miss?Costs to Health Services and the Patient of Treating Tuberculosis: A Systematic Literature Review.Cost-Effectiveness of Automated Digital Microscopy for Diagnosis of Active TuberculosisModelling the effect of short-course multidrug-resistant tuberculosis treatment in Karakalpakstan, Uzbekistan.Health outcomes of bedaquiline in the treatment of multidrug-resistant tuberculosis in selected high burden countries.Has universal screening with Xpert® MTB/RIF increased the proportion of multidrug-resistant tuberculosis cases diagnosed in a routine operational setting?The challenge of managing extensively drug-resistant tuberculosis at a referral hospital in the state of São Paulo, Brazil: a report of three cases.The diagnostic accuracy of the MTBDRplus and MTBDRsl assays for drug-resistant TB detection when performed on sputum and culture isolates.Preliminary Favorable Outcome for Medically and Surgically Managed Extensively Drug-Resistant Tuberculosis, France, 2009-2014.Characteristics and costs of multidrug-resistant tuberculosis in-patient care in the United States, 2005-2007.Re-inventing adherence: toward a patient-centered model of care for drug-resistant tuberculosis and HIV.Cost per patient of treatment for rifampicin-resistant tuberculosis in a community-based programme in Khayelitsha, South Africa.Social support received by multidrug-resistant tuberculosis patients and related factors: a cross-sectional study in Zhejiang Province, People's Republic of China.Combined antiretroviral and anti-tuberculosis drug resistance following incarceration.Minimal diversity of drug-resistant Mycobacterium tuberculosis strains, South Africa.The medical and surgical treatment of drug-resistant tuberculosis.The impact of drug resistance on Mycobacterium tuberculosis physiology: what can we learn from rifampicin?Treatment outcomes of multidrug-resistant tuberculosis patients in Gauteng, South Africa.Is there a need to mitigate the social and financial consequences of tuberculosis at the individual and household level?Novel diagnostics and therapeutics for drug-resistant tuberculosis.Diagnostic usefulness of the GenoType MTBDRplus assay for detecting drug-resistant tuberculosis using AFB smear-negative specimens with positive TB-PCR result.
P2860
Q24193002-7F4F76AD-CE6E-4289-96C1-CC74E809A749Q26765385-C8EDF97B-2AAD-4A04-8292-D6D27381D3D5Q26786661-E5CC75A8-E297-4C42-BD61-C36E096E66A2Q26824413-392997F1-B443-41A7-813D-8D37A8FA0729Q27306144-3DD85C23-B35B-4DEB-898B-08423B819FC0Q28068545-CA53D37B-E491-4BEB-88E4-B20712C39424Q28535035-9249008E-EDF4-43FC-838F-4C890A2AA109Q28543392-1BF29102-B9C5-4179-8EDC-7FC7907E173BQ28545021-0552883A-5C3C-4CF3-858A-FEDEEE9ED856Q28546682-DAB7EE64-4AFC-459F-A343-B0B530CB478FQ28554655-7127B979-76F7-4035-9B7C-248BC98AB1B4Q33675199-884AE827-475F-411A-8C50-B2A5DCF4E35DQ33926262-3BF79B94-1103-4C81-B812-50585EDE0545Q34234063-4C08F3E9-0650-4C68-9B51-051FE3DFAD31Q34775244-7DE30EEF-879A-4EE9-8FE4-CD596D7D0E18Q35193112-2395D7A2-26C5-43AF-B8DD-072612F49DF1Q35407994-21559E11-BF47-4EF5-93FC-D9DD8BC88EF6Q35644365-D4885AAF-4362-4579-8DFA-A35CDAC2F56DQ35662072-B74ECDDC-8432-4C79-B9AE-46AAF9F89F0EQ35966925-6D707A6E-9974-4272-90C8-849F7CF23CDBQ36024119-630F03FB-304E-49D7-9A3F-5256E7956371Q36056621-5CE220F1-B093-492A-AEEA-29858D2E2D49Q36195588-0EA4C176-4691-4A3A-99DE-37C9DF033A01Q36260334-586DF54D-35F3-41A8-9785-6E849C5BABA2Q36281279-A7867745-BE9E-4A82-87E6-278D2033665CQ36490639-3FAF2B88-5046-49A3-BB90-54A5288838DEQ36564933-838984BC-3C46-40A0-A544-28E7064E1811Q36617040-A453C73E-8882-4A57-835D-DD00190A68D6Q36800645-05DC3681-FF80-4067-B609-C3A9B5BE425AQ36892497-0D932DBD-D760-48E7-BC7C-A4851D9321F8Q36893640-84161FDB-33F0-41CE-93DF-C42D4F61524AQ37016896-DA6366F8-DA63-44BF-BE6C-B8067B18428CQ37333954-D0C179DF-CED2-4D60-B045-0DD4CAB2BD7BQ37621713-A927554E-2E83-4674-9F43-624B356EC782Q37629518-EB290768-FBD1-43D9-AD76-0CE563E71BB8Q37683485-B023C77D-4A8F-4626-BF38-171D5F7BA5DEQ38173336-AE2BCEB2-7E29-461C-BF9B-EA966F6A1E9BQ38202907-008D6800-35CB-402F-85CE-3A3D4087E691Q38210363-8E25A7F5-F1E2-4F73-87E7-6464834BAC5CQ38419738-BAF522DE-BB6F-41A0-998C-2846872DA672
P2860
What is the cost of diagnosis and management of drug resistant tuberculosis in South Africa?
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
What is the cost of diagnosis ...... tuberculosis in South Africa?
@ast
What is the cost of diagnosis ...... tuberculosis in South Africa?
@en
What is the cost of diagnosis ...... tuberculosis in South Africa?
@nl
type
label
What is the cost of diagnosis ...... tuberculosis in South Africa?
@ast
What is the cost of diagnosis ...... tuberculosis in South Africa?
@en
What is the cost of diagnosis ...... tuberculosis in South Africa?
@nl
prefLabel
What is the cost of diagnosis ...... tuberculosis in South Africa?
@ast
What is the cost of diagnosis ...... tuberculosis in South Africa?
@en
What is the cost of diagnosis ...... tuberculosis in South Africa?
@nl
P2860
P50
P921
P3181
P1433
P1476
What is the cost of diagnosis ...... tuberculosis in South Africa?
@en
P2093
Anil Pooran
Malika Davids
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0054587
P407
P577
2013-01-01T00:00:00Z